Effect of Nutri Liver Support in non alchoholic fatty liver patients.
Phase 3
- Conditions
- on Alcoholic Fatty liver Disease.Other specified inflammatory liver diseases Nonalcoholic steatohepatitis (NASH)k 75.8
- Registration Number
- IRCT2015031721502N1
- Lead Sponsor
- Semnan University Of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
age between 20 to 40 years old; patients who has white skin; patients who referred to the clinic for checkup; fatty liver is reported in sonography; agreement to be a part of the study; ALT level above 40.
Exclusion criteria: patients that want to withdraw the study at any time; cirrhosis is reported in sonography; patients who are detected as Wilson, autoimmune hepatitis, viral hepatitis, alcoholic hepatitis, hemochromatosis; patients who are suffering from chronic liver disease; drug causes is to be considered for fatty liver; sensitive to drug; those who are affecting by drug side effects.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Alanine Aminotransferase. Timepoint: before and after intervention. Method of measurement: serum.;Aspartate Aminotransferase. Timepoint: before and after intervention. Method of measurement: serum.
- Secondary Outcome Measures
Name Time Method evel of serum cholesterol. Timepoint: before and after intervention. Method of measurement: serum.;Level of serum Triglyceride. Timepoint: Before & after intervention. Method of measurement: Serum.;Low-density Lipoprotein. Timepoint: Before & after intervention. Method of measurement: Serum.;High-density Lipoprotein. Timepoint: Before & after intervention. Method of measurement: Serum.